THIS EMPLOYMENT AGREEMENT dated for reference the 6th day of August, 2008 BETWEEN:Employment Agreement • February 4th, 2009 • Helix BioPharma Corp • Pharmaceutical preparations • Ontario
THEREFORE in consideration of the recitals, the following covenants and the payment of one dollar made by each party to the other, the receipt and sufficiency of which is acknowledged by each party, the parties agree on the following terms:
Helix BioPharma Corp. STOCK OPTION AGREEMENT (2008 Option Plan - Director)Stock Option Agreement • February 4th, 2009 • Helix BioPharma Corp • Pharmaceutical preparations
TECHNOLOGY LICENSE AGREEMENT CONFIDENTIAL TREATMENT REQUESTEDTechnology License Agreement • February 4th, 2009 • Helix BioPharma Corp • Pharmaceutical preparations • Ontario
INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS IDENTIFIED BY THREE ASTERISKS, AS FOLLOWS “* * *”, AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
CLINICAL SUPPLIES MANUFACTURING AGREEMENT BETWEEN HELIX BIOPHARMA CORP. AND BIOVECTRA INC. May 4, 2008 CONFIDENTIAL TREATMENT REQUESTEDCGMP Process Development, Scale Up and Clinical Supplies Manufacturing Agreement • February 4th, 2009 • Helix BioPharma Corp • Pharmaceutical preparations • Ontario
INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS IDENTIFIED BY THREE ASTERISKS, AS FOLLOWS “* * *”, AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
Material Transfer and License Option Agreement between Helix BioPharma Corporation and Schering CorporationMaterial Transfer and License Option Agreement • February 4th, 2009 • Helix BioPharma Corp • Pharmaceutical preparations • New York
INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS IDENTIFIED BY THREE ASTERISKS, AS FOLLOWS “* * *”, AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
TOPICAL INTERFERON ALPHA-2b GMP PROCESS DEVELOPMENT, SCALE UP AND CLINICAL SUPPLIES MANUFACTURING AGREEMENT BETWEEN HELIX BIOPHARMA CORP. AND CONTRACT PHARMACEUTICALS LIMITED NIAGARA April _3__, 2008 CONFIDENTIAL TREATMENT REQUESTEDTopical Interferon Alpha-2b GMP Process Development, Scale Up and Clinical Supplies Manufacturing Agreement • February 4th, 2009 • Helix BioPharma Corp • Pharmaceutical preparations • Ontario
INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS IDENTIFIED BY THREE ASTERISKS, AS FOLLOWS “* * *”, AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
THIS AGREEMENT made as of the ___ day of January, 2006.Indemnification & Liability • February 4th, 2009 • Helix BioPharma Corp • Pharmaceutical preparations • Ontario
